Precision Medicine Platforms
Part of Healthcare - Genomics & Precision Medicine
 AZN | AstraZeneca PLC | $243.3b | $170.89 | -0.7% | 1.0M |
 TMO | Thermo Fisher Scientific, Inc. | $242.1b | $693.84 | +1.4% | 496.9K |
 DHR | Danaher Corporation | $150.5b | $232.29 | -0.1% | 844.1K |
 WAT | Waters Corp | $41.8b | $463.02 | +1.6% | 223.9K |
 GH | Guardant Health, Inc. Common Stock | $23.9b | $176.24 | +1.9% | 489.2K |
 RVTY | Revvity, Inc. | $16.9b | $161.10 | +0.6% | 502.7K |
 TEM | Tempus AI, Inc. Class A Common Stock | $13.9b | $71.37 | +6.7% | 2.0M |
 BBIO | BridgeBio Pharma, Inc. Common Stock | $13.1b | $69.33 | +1.5% | 748.2K |
 TWST | Twist Bioscience Corporation Common Stock | $12.5b | $156.67 | +8.1% | 802.5K |
 TECH | Bio-Techne Corp. | $11.4b | $72.67 | +0.0% | 1.2M |
 NUVL | Nuvalent, Inc. Class A Common Stock | $9.8b | $123.96 | 0.0% | N/A |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $8.9b | $117.88 | +3.2% | 262.0K |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | $8.3b | $270.79 | +1.4% | 84.1K |
 CAI | Caris Life Sciences, Inc. Common Stock | $8.0b | $33.49 | +3.7% | 1.6M |
 LNTH | Lantheus Holdings, Inc | $6.5b | $100.10 | +0.2% | 437.1K |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $4.5b | $27.33 | +4.1% | 418.3K |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | $3.6b | $33.54 | +2.0% | 107.9K |
 CDNA | CareDx, Inc. | $3.5b | $71.48 | +3.2% | 307.0K |
 DYN | Dyne Therapeutics, Inc. Common Stock | $2.8b | $16.77 | +6.7% | 837.4K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $2.2b | $64.60 | +5.4% | 221.9K |
 ALMR | Alamar Biosciences, Inc. Common Stock | $2.1b | $31.43 | +2.4% | 134.2K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.5b | $31.41 | +1.3% | 103.0K |
 CSTL | Castle Biosciences, Inc. Common Stock | $1.1b | $34.12 | +1.4% | 43.7K |
 ANRO | Alto Neuroscience Inc. | $1.0b | $23.13 | +4.4% | 142.1K |
 CTKB | Cytek Biosciences, Inc. Common Stock | $0.8b | $5.87 | -0.1% | 246.0K |
 NVCT | Nuvectis Pharma, Inc. Common Stock | $0.7b | $18.61 | +0.2% | 50.5K |
 OABI | OmniAb, Inc. Common Stock | $0.7b | $4.88 | +5.9% | 325.9K |
 SOPH | SOPHiA GENETICS SA Ordinary Shares | $0.7b | $7.64 | +1.3% | 115.8K |
 AURA | Aura Biosciences, Inc. Common Stock | $0.6b | $6.20 | +0.6% | 156.9K |
 QSI | Quantum-Si Incorporated Class A Common Stock | $339.3m | $1.70 | +17.8% | 10.9M |
 PRLD | Prelude Therapeutics Incorporated | $292.9m | $3.87 | +3.8% | 54.9K |
 BDSX | Biodesix, Inc. Common Stock | $292.5m | $21.78 | +0.9% | 88.8K |
 LAB | Standard BioTools Inc. Common Stock | $292.4m | $0.61 | +2.7% | 466.9K |
 ACIU | AC Immune SA | $270.9m | $2.15 | -8.0% | 327.8K |
 NAUT | Nautilus Biotechnolgy, Inc. Common Stock | $249.4m | $2.52 | +2.9% | 10.9M |
 XGN | Exagen Inc. Common Stock | $197.9m | $7.71 | +4.3% | 77.3K |
 QTRX | Quanterix Corporation Common Stock | $172.1m | $2.87 | +2.1% | 160.9K |
 AVXL | Anavex Life Sciences | $168.7m | $1.28 | -0.4% | 544.0K |
 SEER | Seer, Inc. Class A Common Stock | $124.6m | $1.97 | +1.0% | 66.3K |
 FHTX | Foghorn Therapeutics Inc. Common Stock | $120.0m | $2.04 | -0.2% | 335.7K |
 ACRV | Acrivon Therapeutics, Inc. Common Stock | $85.3m | $1.75 | +1.5% | 85.7K |
 SERA | Sera Prognostics, Inc. Class A Common Stock | $82.4m | $2.10 | 0.0% | 899 |
 IBIO | iBio, Inc. Common Stock | $72.3m | $0.77 | +5.5% | 166.8K |
 CSBR | Champions Oncology, Inc. | $68.8m | $4.92 | 0.0% | 2.7K |
 MDXH | MDxHealth SA Ordinary Shares | $54.5m | $0.19 | -2.1% | 207.6K |
 TVGN | Tevogen Inc. Common Stock | $45.5m | $6.45 | 0.0% | 646 |
 CCEL | Cryo-Cell International Inc. | $32.2m | $4.83 | -0.8% | 477 |
 ALLR | Allarity Therapeutics, Inc. Common Stock | $16.5m | $0.91 | 0.0% | 91.4K |
 ADVB | Advanced Biomed Inc. Common Stock | $11.1m | $2.99 | +4.0% | 15.9K |
 CDIO | Cardio Diagnostics Holdings Inc. Common stock | $5.8m | $1.72 | -1.2% | 3.6K |